{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:53:07Z","timestamp":1780505587685,"version":"3.54.1"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T00:00:00Z","timestamp":1523491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["AID-OAA-A-14-00003"],"award-info":[{"award-number":["AID-OAA-A-14-00003"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0195499","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T17:55:13Z","timestamp":1523555713000},"page":"e0195499","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Optimizing adherence in HIV prevention product trials: Development and psychometric evaluation of simple tools for screening and adherence counseling"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9823-3675","authenticated-orcid":true,"given":"Elizabeth E.","family":"Tolley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate Morrow","family":"Guthrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Zissette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Fava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl E.","family":"Louw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Kotze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnaveni","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"MacQueen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,4,12]]},"reference":[{"issue":"5996","key":"ref1","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Q Abdool Karim","year":"2010","journal-title":"Science"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"JM Baeten","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana","volume":"367","author":"MC Thigpen","year":"2012","journal-title":"N Engl J Med"},{"issue":"9883","key":"ref4","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"K Choopanya","year":"2013","journal-title":"Lancet"},{"key":"ref5","article-title":"Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women","author":"JM Baeten","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure prophylaxis for HIV infection among African women","volume":"367","author":"L Van Damme","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/QAI.0000000000000158","article-title":"FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis","volume":"66","author":"AL Corneli","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa1402269","article-title":"Tenofovir-based preexposure prophylaxis for HIV infection among African women","volume":"372","author":"JM Marrazzo","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/QAI.0000000000000216","article-title":"Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detection","volume":"66","author":"KR Amico","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"e0125458","DOI":"10.1371\/journal.pone.0125458","article-title":"Facilitators of adherence to the study pill in the FEM-PrEP clinical trial","volume":"10","author":"A Corneli","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"19146","DOI":"10.7448\/IAS.17.3.19146","article-title":"Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa","volume":"17","author":"A van der Straten","year":"2014","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"e89118","DOI":"10.1371\/journal.pone.0089118","article-title":"Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa","volume":"9","author":"A van der Straten","year":"2014","journal-title":"PLoS One"},{"issue":"16","key":"ref13","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1097\/QAD.0000000000000801","article-title":"Disclosure of pharmacokinetic drug results to understand nonadherence","volume":"29","author":"A van der Straten","year":"2015","journal-title":"AIDS"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/QAD.0000000000000647","article-title":"Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm","volume":"29","author":"JE Haberer","year":"2015","journal-title":"AIDS"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"20746","DOI":"10.7448\/IAS.19.1.20746","article-title":"Biomarkers and biometric measures of adherence to use of ARV-based vaginal rings","volume":"19","author":"RM Stalter","year":"2016","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s10461-012-0172-7","article-title":"A proposal for quality standards for measuring medication adherence in research","volume":"17","author":"AB Williams","year":"2013","journal-title":"AIDS Behav"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"20642","DOI":"10.7448\/IAS.19.1.20642","article-title":"Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study","volume":"19","author":"A van der Straten","year":"2016","journal-title":"J Int AIDS Soc"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"18505","DOI":"10.7448\/IAS.16.1.18505","article-title":"Microbicide clinical trial adherence: insights for introduction","volume":"16","author":"C Woodsong","year":"2013","journal-title":"J Int AIDS Soc"},{"key":"ref19","first-page":"569","article-title":"Drug delivery and development of anti-HIV microbicides","author":"E Tolley","year":"2014"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"19158","DOI":"10.7448\/IAS.17.3.19158","article-title":"An interdisciplinary framework for measuring and supporting adherence in HIV prevention trials of ARV-based vaginal rings","volume":"17","author":"KM MacQueen","year":"2014","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","volume":"24","author":"DE Morisky","year":"1986","journal-title":"Med Care"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10865-007-9118-3","article-title":"The role of self-efficacy in HIV treatment adherence: validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES)","volume":"30","author":"MO Johnson","year":"2007","journal-title":"J Behav Med"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.hrtlng.2007.10.001","article-title":"Testing the psychometric properties of the Medication Adherence Scale in patients with heart failure","volume":"37","author":"JR Wu","year":"2008","journal-title":"Heart Lung"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/her\/10.1.1-a","article-title":"The art and science of scale development in health education research","volume":"10","author":"CA Mahoney","year":"1995","journal-title":"Health Educ Res"},{"key":"ref25","first-page":"viii","author":"RF DeVellis","year":"2003"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/jech.2004.021204","article-title":"Just one question: If one question works, why ask several?","volume":"59","author":"A Bowling","year":"2005","journal-title":"Journal of Epidemiological Community Health"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/QAI.0b013e31806910e3","article-title":"Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework","volume":"45","author":"R Horne","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"e80633","DOI":"10.1371\/journal.pone.0080633","article-title":"Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework","volume":"8","author":"R Horne","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S1081-1206(10)60036-1","article-title":"Motivation for participation in clinical trials of drugs for the treatment of asthma, seasonal allergic rhinitis, and perennial nonallergic rhinitis","volume":"76","author":"JS Aby","year":"1996","journal-title":"Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1080\/09540121003693522","article-title":"Altruism motivates participation in a therapeutic HIV vaccine trial (CTN 173)","volume":"22","author":"L Balfour","year":"2010","journal-title":"AIDS Care"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.qai.0000152039.88422.ec","article-title":"Motivations for participating in an HIV vaccine efficacy trial","volume":"39","author":"G Colfax","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/medethics-2012-100755","article-title":"Evaluation of factors that motivate participants to consent for non-therapeutic trials in India. Journal of Medical Ethics","volume":"39","author":"MS Doshi","year":"2013","journal-title":"Journal of the Institute of Medical Ethics"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.cct.2004.06.004","article-title":"When free condoms and spermicide are not enough: barriers and solutions to participant recruitment to community-based trials","volume":"25","author":"M Gabbay","year":"2004","journal-title":"Controlled clinical trials"},{"issue":"12","key":"ref34","first-page":"2317","article-title":"Factors affecting rheumatoid arthritis patients' decisions to participate in clinical trials","volume":"32","author":"SJ Lee","year":"2005","journal-title":"The Journal of rheumatology"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1891\/1061-3749.16.2.136","article-title":"Measuring attitudes toward participation in cancer treatment and cancer prevention trials: The Attitudes Toward Cancer Trials Scales (ACTS)","volume":"16","author":"PA Schuber","year":"2008","journal-title":"Journal of Nursing Measurement"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00042560-200007010-00014","article-title":"Factors affecting African-American participation in AIDS research","volume":"24","author":"S Sengupta","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"ref37","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s11136-006-0026-8","article-title":"The ORTHO BC-SAT\u2014a satisfaction questionnaire for women using hormonal contraceptives","volume":"15","author":"HH Colwell","year":"2006","journal-title":"Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"DiMatteo MR, Hays RD, Gritz ER, Bastani R, Crane L, Elashoff R, et al. Adherence Determinants Questionnaire. 1993.","DOI":"10.1037\/t03712-000"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.37757\/MR2011V13.N2.6","article-title":"Antiretroviral therapy adherence in persons with HIV\/AIDS in Cuba","volume":"13","author":"C Aragones","year":"2011","journal-title":"MEDICC Review"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jana.2012.04.006","article-title":"Self-efficacy, medication adherence, and quality of life among people living with HIV in Hunan Province of China: a questionnaire survey","volume":"24","author":"L Huang","year":"2013","journal-title":"Journal of the Association of Nurses In AIDS Care"},{"issue":"4","key":"ref41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1027\/1015-5759\/a000077","article-title":"The Psychosocial Treatment Expectations Questionnaire (PTEQ) for alcohol problems: Development and early validation","volume":"27","author":"JC de Carvalho Leite","year":"2011","journal-title":"European Journal of Psychological Assessment"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/nur.20158","article-title":"The health care relationship (HCR) trust scale: development and psychometric evaluation","volume":"29","author":"C Bova","year":"2006","journal-title":"Res Nurs Health"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10461-012-0374-z","article-title":"The development of an inventory to assess the structural barriers to clinic attendance and pill-taking amongst users of antiretroviral therapy","volume":"17","author":"B Coetzee","year":"2013","journal-title":"AIDS and behavior"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archpedi.157.3.249","article-title":"Barriers to HAART adherence among human immunodeficiency virus-infected adolescents","volume":"157","author":"DA Murphy","year":"2003","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1071\/SH04020","article-title":"Predictors for non-adherence to antiretroviral therapy","volume":"1","author":"KJ Wilson","year":"2004","journal-title":"Sexual health"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF01849492","article-title":"Contraceptive vaginal ring\u2014a rising star on the contraceptive horizon","volume":"6","author":"K Buckshee","year":"1990","journal-title":"Advances in contraception: the official journal of the Society for the Advancement of Contraception"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11205-009-9506-x","article-title":"An Evaluation of the Precision of Measurement of Ryff's Psychological Well-Being Scales in a Population Sample","volume":"97","author":"RA Abbott","year":"2010","journal-title":"Social indicators research"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jsr.2010.02.005","article-title":"Social desirability effects in driver behavior inventories","volume":"41","author":"AE af W\u00e5hlberg","year":"2010","journal-title":"Journal of safety research"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1037\/h0047358","article-title":"A new scale of social desirability independent of psychopathology","volume":"24","author":"DP Crowne","year":"1960","journal-title":"J Consult Psychol"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1037\/0022-3514.46.3.598","article-title":"Two-Component Models of Socially Desirable Responding","volume":"46","author":"DL Paulhus","year":"1984","journal-title":"Journal of Personality and Social Psychology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1207\/s15327906mbr0102_10","article-title":"The scree test for the number of factors","volume":"1","author":"RB Cattell","year":"1966","journal-title":"Multivariate Behavioral Research"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF02289447","article-title":"A rationale and test for the number of factors in factor analysis","volume":"30","author":"JL Horn","year":"1965","journal-title":"Psychometrika"},{"issue":"3","key":"ref53","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3758\/BF03200807","article-title":"SPSS and SAS programs for determining the number of components using parallel analysis and velicer's MAP test","volume":"32","author":"BP O'Connor","year":"2000","journal-title":"Behav Res Methods Instrum Comput"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02310555","article-title":"Coefficient alpha and the internal structure of tests","volume":"16","author":"LJ Cronbach","year":"1951","journal-title":"Psychometrika"},{"key":"ref55","unstructured":"AVAC, CONRAD. Workshop on Alternative Trial Designs for Microbicides. 2014."},{"issue":"11","key":"ref56","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1080\/09540121.2011.555750","article-title":"Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies","volume":"23","author":"S Dhalla","year":"2011","journal-title":"AIDS Care"},{"issue":"7","key":"ref57","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00002030-199807000-00015","article-title":"Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States","volume":"12","author":"BA Koblin","year":"1998","journal-title":"AIDS"},{"issue":"3","key":"ref58","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00126334-199907010-00010","article-title":"Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand","volume":"21","author":"KM MacQueen","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"ref59","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2105\/AJPH.2011.300208","article-title":""Speaking the dialect": understanding public discourse in the aftermath of an HIV vaccine trial shutdown","volume":"101","author":"PA Newman","year":"2011","journal-title":"Am J Public Health"},{"issue":"11","key":"ref60","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jclinepi.2005.03.014","article-title":"Altruism as a reason for participation in clinical trials was independently associated with adherence","volume":"58","author":"JR Rosenbaum","year":"2005","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"ref61","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00126334-200012150-00012","article-title":"Willingness to participate in HIV vaccine trials among men who have sex with men in Rio de Janeiro, Brazil. Projeto Praca Onze Study Group","volume":"25","author":"AR Perisse","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"ref62","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/apc.2013.0116","article-title":"Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco","volume":"27","author":"HJ Gilmore","year":"2013","journal-title":"AIDS Patient Care STDS"},{"key":"ref63","article-title":"Experiences with HPTN 067\/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework","author":"KR Amico","year":"2016","journal-title":"AIDS Behav"},{"issue":"36","key":"ref64","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1016\/j.vaccine.2011.06.064","article-title":"Selectively willing and conditionally able: HIV vaccine trial participation among women at "high risk" of HIV infection","volume":"29","author":"CD Voytek","year":"2011","journal-title":"Vaccine"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2147\/PPA.S30759","article-title":"'It's not about money, it's about my health': determinants of participation and adherence among women in an HIV-HSV2 prevention trial in Johannesburg, South Africa","volume":"6","author":"C Macphail","year":"2012","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"ref66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e3181625d78","article-title":"Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials","volume":"87","author":"JB Braunstein","year":"2008","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"ref67","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ypmed.2006.12.007","article-title":"Willingness to participate in HIV vaccine trials: the impact of trial attributes","volume":"44","author":"PA Newman","year":"2007","journal-title":"Prev Med"},{"issue":"2","key":"ref68","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/01.qai.0000179454.93443.60","article-title":"HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment","volume":"41","author":"PA Newman","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"ref69","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s10461-014-0950-5","article-title":"Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding"","volume":"19","author":"ET Montgomery","year":"2015","journal-title":"AIDS Behav"},{"key":"ref70","first-page":"40","volume":"2005","author":"R Horne","year":"2005"},{"issue":"5","key":"ref71","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s10461-010-9806-9","article-title":"The importance of male partner involvement for women's acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe","volume":"15","author":"ET Montgomery","year":"2011","journal-title":"AIDS Behav"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1472-6874-14-88","article-title":"Influences on visit retention in clinical trials: insights from qualitative research during the VOICE trial in Johannesburg, South Africa","volume":"14","author":"B Magazi","year":"2014","journal-title":"BMC Womens Health"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0195499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T23:29:44Z","timestamp":1720222184000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0195499"}},"subtitle":[],"editor":[{"given":"Paula","family":"Braitstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,12]]},"references-count":72,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0195499","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,12]]}}}